fentaNYL Citrate — Class II drug recall D-0864-2026
Ongoing recall by OurPharma LLC, reported 2026-09-16, distributed nationwide. Labeling: Not Elsewhere Classified: Complaint received on 08/31/2026 regarding the discrepancy of the IV bag e
| Recall number | D-0864-2026 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | OurPharma LLC, Fayetteville, AR, United States |
| Recall initiated | 2026-09-03 |
| Classified | 2026-09-21 |
| Reported by FDA | 2026-09-16 |
| Distributed | Nationwide (US) |
| Quantity | 1,610 bags |
| Reason classes | labeling |
| NDC | 73013-1013-01 |
| Lot numbers | 101301260605 |
| Expiration dates | 2026-12-09 |
Product
fentaNYL Citrate, 1,000 mcg/100 mL (10mcg/mL) Injection solution in 100 mL, 0.9% NaCl Bag, OurPharma LLC, 2512 S. City Lake, Fayetteville, AR, NDC 73013-1013-01.
Reason for recall
Labeling: Not Elsewhere Classified: Complaint received on 08/31/2026 regarding the discrepancy of the IV bag expiry (07/31/2026 and 11/30/2026) and the product expiry (12/09/2026).
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0864-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-29. Not affiliated with or endorsed by FDA. Not medical or legal advice.